Chemically synthesized sgRNA offers the following key advantages:
(1) Higher editing efficiency: A lot of studies have demonstrated that chemically synthesized sgRNA achieves higher editing efficiency compared to IVT sgRNA.
(2) Lower cytotoxicity: IVT sgRNA carries a 5′-triphosphate modification, which can trigger innate immune responses and lead to cytotoxicity, thereby interfering with experimental results. In contrast, chemically synthesized sgRNA avoids such off-target immunostimulatory effects.
(3) Enhanced stability: Chemical synthesis allows the incorporation of stabilizing modifications such as phosphorothioate (PS) bonds and methoxy groups, improving stability during storage and experimental procedures. Moreover, the chemical synthesis process ensures higher batch-to-batch consistency and reproducibility.
(4) Ease of use: Chemically synthesized sgRNA is ready to use upon delivery, while IVT sgRNA requires 2–3 days and 5–6 steps for production, incurring higher economic and time costs.



